Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
BMS-303141 inhibits lipid synthesis in HepG2 cells with an IC50 of 8 μM
]pentadeca-1(15)
Dirhodium-catalyzed enantioselective C-H insertion of N-(2-benzyloxyethyl)-N-(tert-butyl)diazoacetamide and its application for the synthesis of chiral GABOB
KB-R7943 inhibits high glucose-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion
TAK-875 has no agonist potency to other members of the FFA receptor family with EC50 >10 μM
PHA-767491 Hydrochloride - CAS# 942425-68-5 noxerine BMS-303141 inhibits lipid synthesis inPHA 767491, also known as CAY10572, is a potent, ATP competitive dual cdc7 cdk9 inhibitor (IC50 values are 10 and 34 nM respectively) that prevents initiation of DNA replication. PHA 767491 Suppresses Hepatocarcinoma Synergistically with 5 Fluorouracil. PHA 767491 in combination with 5 FU exhibited much stronger cytotoxicity and induced significant apoptosis manifested by remarkably increased caspase 3 activation and poly(ADP Ribose) polymerase
US$ 3538.51
US$ 8314.34